Aside from its core synthetic biology business, the company has expanded into NGS and is looking to move into drug discovery and DNA data storage.
Twist, which went public in October, reported that its revenues doubled this year due to increased sales of its synthetic DNA products and the introduction of NGS products.
CNGB was founded by the Chinese government and BGI to collect genomics technologies and resources, and promote their use by the research community.
Cowen gave the company a rating of Outperform while JP Morgan assigned its shares a Neutral rating.
The French startup plans to offer a precommercial version of its hardware platform to beta testers as early as the end of 2019.
Eurofins will distribute Synthego's sgRNA products to its customers in 44 countries.
The firm said it will use the financing to continue marketing its Engineered Cells and CRISPRevolution product lines and to expand in Europe and Asia.
The firm hasn't yet specified how many shares it is offering or at what price but noted that its stock would trade under the Nasdaq symbol TWST.
Ranomics said it has inked a distribution agreement with Axil Scientific for Ranomics' VariantFind DNA libraries in Singapore.
Arbor will provide reagents to Tataa for its courses on next-generation sequencing applications, while Tataa will distribute Arbor's products in European countries.
CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.
Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.
Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.
In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.